SHSE:603716 (China)
Â
Ordinary Shares - Class A
Â¥
5.88
(+0.86%)
Sep 13
Business Description
Thalys Medical Technology Group Corp
ISIN : CNE1000030C3
Share Class Description:
SHSE:603716: Ordinary Shares - Class ACompare
Compare
Traded in other countries / regions
603716.China IPO Date
2016-10-31Description
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.98 | |||||
| Debt-to-EBITDA | -8.83 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.29 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.8 | |||||
| 3-Year Book Growth Rate | -9.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.7 | |||||
| 9-Day RSI | 39.56 | |||||
| 14-Day RSI | 42.56 | |||||
| 6-1 Month Momentum % | -7.83 | |||||
| 12-1 Month Momentum % | -36.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.68 | |||||
| Quick Ratio | 1.44 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 84.93 | |||||
| Days Sales Outstanding | 298.57 | |||||
| Days Payable | 170.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 19.41 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.03 | |||||
| Operating Margin % | -0.81 | |||||
| Net Margin % | -8.37 | |||||
| FCF Margin % | -3.8 | |||||
| ROE % | -13.04 | |||||
| ROA % | -4.76 | |||||
| ROIC % | -0.57 | |||||
| 3-Year ROIIC % | 30.13 | |||||
| ROC (Joel Greenblatt) % | -9.18 | |||||
| ROCE % | -6.26 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 28 | |||||
| PS Ratio | 0.68 | |||||
| PB Ratio | 1.05 | |||||
| Price-to-Tangible-Book | 1.21 | |||||
| EV-to-EBIT | -16.56 | |||||
| EV-to-EBITDA | -16.56 | |||||
| EV-to-Revenue | 1.05 | |||||
| EV-to-FCF | -27.77 | |||||
| Price-to-Projected-FCF | 6.19 | |||||
| Price-to-Net-Current-Asset-Value | 5.88 | |||||
| Earnings Yield (Greenblatt) % | -6.04 | |||||
| FCF Yield % | -6.32 | |||||
| Forward Rate of Return (Yacktman) % | -29.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thalys Medical Technology Group Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,970.957 | ||
| EPS (TTM) (Â¥) | -0.845 | ||
| Beta | 0.71 | ||
| Volatility % | 39.91 | ||
| 14-Day RSI | 42.56 | ||
| 14-Day ATR (Â¥) | 0.361728 | ||
| 20-Day SMA (Â¥) | 6.243 | ||
| 12-1 Month Momentum % | -36.01 | ||
| 52-Week Range (Â¥) | 5.13 - 13.1 | ||
| Shares Outstanding (Mil) | 201.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thalys Medical Technology Group Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Thalys Medical Technology Group Corp Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Thalys Medical Technology Group Corp Frequently Asked Questions
What is Thalys Medical Technology Group Corp(SHSE:603716)'s stock price today?
The current price of SHSE:603716 is ¥5.88. The 52 week high of SHSE:603716 is ¥13.10 and 52 week low is ¥5.13.
When is next earnings date of Thalys Medical Technology Group Corp(SHSE:603716)?
The next earnings date of Thalys Medical Technology Group Corp(SHSE:603716) is .
Does Thalys Medical Technology Group Corp(SHSE:603716) pay dividends? If so, how much?
Thalys Medical Technology Group Corp(SHSE:603716) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers